Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab inpatients with relapsed/refractory large B-cell lymphoma

Lorenzo Falchi; Martin Hutchings; Carmelo Carlo-Stella; Franck Morschhauser; Michael Dickinson; Guillaume Cartron; Cyrus Khan; Monica Tani; Joaquin Martinez-Lopez; Nancy L. Bartlett; Antonio Salar; Joshua D. Brody; Sirpa Leppa; Aurelien Berthier; Martine Kallemeijn; James Relf; Fabiola Bene Tchaleu; Linda Lundberg; Emmanuel Bachy

doi:10.3324/haematol.2024.286257

$Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab inpatients with relapsed/refractory large B-cell lymphoma$

Article de revue

Avec comité de lecture

Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab inpatients with relapsed/refractory large B-cell lymphoma

Lorenzo Falchi, Martin Hutchings, Carmelo Carlo-Stella, Franck Morschhauser, Michael Dickinson, Guillaume Cartron, Cyrus Khan, Monica Tani, Joaquin Martinez-Lopez, Nancy L. Bartlett, …

Haematologica (Roma), Vol.110(4), pp.999-1004

01/04/2025

DOI: https://doi.org/10.3324/haematol.2024.286257

PMID: 39605203

Résumé

Hematology

Life Sciences & Biomedicine

Science & Technology

Indicateurs

1 Consultations de la notice

See more details

Détails

Titre: Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab inpatients with relapsed/refractory large B-cell lymphoma
Créateurs - sans rôle: Lorenzo Falchi - Mem Sloan Kettering Canc Ctr, Lymphoma Serv, New York, NY 10065 USA
Martin Hutchings - Rigshosp, Copenhagen, Denmark
Carmelo Carlo-Stella - University of Milan
Franck Morschhauser - Hop Claude Huriez, F-59037 Lille, France
Michael Dickinson - Royal Melbourne Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
Guillaume Cartron - CHU Montpellier, Montpellier, France
Cyrus Khan - Allegheny Hlth Network, Pittsburgh, PA USA
Monica Tani - Osped Santa Maria Croci, Ravenna, Italy
Joaquin Martinez-Lopez - Univ Complutense Madrid, Spanish Natl Canc Res Ctr CNIO, Hosp Univ 12 Octubre, imas12, Madrid, Spain
Nancy L. Bartlett - Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA
Antonio Salar - Hosp Del Mar, Barcelona, Spain
Joshua D. Brody - Tisch Canc Inst, New York, NY USA
Sirpa Leppa - Univ Helsinki, Helsinki, Finland
Aurelien Berthier - F Hoffmann La Roche Ltd, Basel, Switzerland
Martine Kallemeijn - F Hoffmann La Roche Ltd, Basel, Switzerland
James Relf - Roche Prod Ltd, Welwyn Garden City, England
Fabiola Bene Tchaleu - Genentech Inc, South San Francisco, CA USA
Linda Lundberg - F Hoffmann La Roche Ltd, Basel, Switzerland
Emmanuel Bachy - Hosp Civils Lyon, Hop Lyon Sud, Lyon, France
Détails de publication: Haematologica (Roma), Vol.110(4), pp.999-1004
Éditeur: Ferrata Storti Foundation
Nombre de pages: 6
Note de subvention: F. Hoffmann-La Roche Ltd; Roche Holding
Identifiants: 99139754109311
Unité académique: Institut de Génétique Moléculaire de Montpellier - IGMM
Langue: English
Type de ressource: Journal article